Dr. Hao Huang, Ph.D., is a Research Associate Professor at the Feinberg School of Medicine, Northwestern University, with over two decades of experience in molecular biology, cancer biology, and immuno-oncology. He earned his Ph.D. in Cell and Developmental Biology from Seoul National University, preceded by M.S. and B.S. degrees in Biochemistry and Chemistry. Dr. Huang’s research focuses on genetic and epigenetic regulation in cancer, particularly RNA/DNA methylation, small molecule inhibitors, drug resistance mechanisms, and tumor immunity. He has played key roles in multiple federally and institutionally funded projects, including grants from the DoD, NCI, and Friends of Prentice. His impactful work has resulted in over 40 high-impact publications, including articles in Cancer Cell, PNAS, Nature Communications, and J Clin Invest. Dr. Huang is an active member of the American Association for Cancer Research (AACR) and American Society of Hematology (ASH), and serves as a manuscript and grant reviewer internationally. His scientific contributions are widely recognized, with a citation count exceeding 6,000. Notably, he has pioneered work on RNA methylation in ovarian cancer resistance and novel epigenetic-targeted therapies.